| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1038349451 |
| P356 | DOI | 10.1023/A:1006736931381 |
| P698 | PubMed publication ID | 11321236 |
| P2093 | author name string | D Campbell | |
| R J Looney | |||
| M S Hasan | |||
| T G Evans | |||
| A R Falsey | |||
| J M Agosti | |||
| G N Abraham | |||
| D Coffin | |||
| J Kolassa | |||
| P2860 | cites work | Aging and the skin immune system | Q28255396 |
| The dendritic cell system and its role in immunogenicity | Q29619870 | ||
| The efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte macrophage colony-stimulating factor in permitting the administration of higher doses of cyclophosphamide in a doxorubicin-cyclophosphamide com | Q33487976 | ||
| Thrombocytopenia after high-dose chemotherapy and autologous stem cell transplantation: an unresolved problem and possible approaches to resolve it. | Q33497346 | ||
| Human naive and memory T lymphocytes differ in telomeric length and replicative potential | Q33755629 | ||
| Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro | Q34246280 | ||
| T cell receptor gene deletion circles identify recent thymic emigrants in the peripheral T cell pool | Q34998720 | ||
| New therapeutic modalities for the clinical use of rhGM-CSF in patients with malignancies | Q37756535 | ||
| Immunogenicity of standard and low dose vaccination using yeast-derived recombinant hepatitis B surface antigen in elderly volunteers | Q39394974 | ||
| Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases | Q41072146 | ||
| Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. | Q41466523 | ||
| Differential age-change in the numbers of CD4+CD45RA+ and CD4+CD29+ T cell subsets in human peripheral blood | Q44192008 | ||
| Age-associated changes in human T cell phenotype and function. | Q52059021 | ||
| The effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on hepatitis B vaccination in haemodialysis patients. | Q53740192 | ||
| Constitutive activation of NF-kappa B in an animal model of aging | Q59944215 | ||
| Age-related changes in human lymphocyte subsets: progressive reduction of the CD4 CD45R (suppressor inducer) population | Q69034305 | ||
| Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in patients with refractory metastatic carcinoma | Q69519936 | ||
| Alterations in the human immune response to the hepatitis B vaccine among the elderly | Q70037644 | ||
| Granulocyte-macrophage colony-stimulating factor-cultured bone marrow-derived macrophages reveal accessory cell function and synthesis of MHC class II determinants in the absence of external stimuli | Q70402494 | ||
| Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines | Q71249344 | ||
| Morphologically and functionally intact dendritic cells can be derived from the peripheral blood of aged individuals | Q71537276 | ||
| Granulocyte-macrophage colony-stimulating factor (GM-CSF) enhances pulmonary defenses against pneumococcal infections after splenectomy | Q71657235 | ||
| Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine | Q71877621 | ||
| Immune response of the elderly to rabies vaccines | Q72073859 | ||
| Age-related decline in the in vitro and in vivo syntheses of anti-tetanus toxoid antibody in humans | Q72081305 | ||
| Role of granulocyte-macrophage colony-stimulating factor as adjuvant treatment in neutropenic patients with bacterial and fungal infection | Q72589223 | ||
| Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer | Q72675254 | ||
| Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination of healthy adults | Q73175525 | ||
| Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen | Q77603832 | ||
| P433 | issue | 1 | |
| P921 | main subject | hepatitis B | Q6853 |
| immunologic adjuvant | Q967453 | ||
| P304 | page(s) | 30-36 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Journal of Clinical Immunology | Q6294961 |
| P1476 | title | Hepatitis B immunization of healthy elderly adults: relationship between naïve CD4+ T cells and primary immune response and evaluation of GM-CSF as an adjuvant | |
| P478 | volume | 21 |
| Q82831277 | Anti-hepatitis B core antibody is not required for prevaccination screening in healthcare workers |
| Q37400606 | B-cell responses to vaccination at the extremes of age. |
| Q36399584 | Bone marrow microenvironmental changes underlie reduced RAG-mediated recombination and B cell generation in aged mice |
| Q36496857 | Evaluation of immunogenicity and reactogenicity of recombinant DNA hepatitis B vaccine produced in India. |
| Q28751705 | GM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primates |
| Q61735318 | Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination: A meta-analysis |
| Q38161823 | How T follicular helper cells and the germinal centre response change with age. |
| Q80547528 | Humoral epitope-spreading following immunization with a HER-2/neu peptide based vaccine in cancer patients |
| Q34036703 | Immune aging and rheumatoid arthritis |
| Q36178518 | Immunogenicity and reactogenicity of a recombinant hepatitis B vaccine in subjects over age of forty years and response of a booster dose among nonresponders |
| Q34850890 | Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals |
| Q35887012 | Persistence of immunity in healthy adults aged ≥ 50 years primed with a hepatitis B vaccine 3 years previously |
| Q35126704 | Substituting threonine 187 with alanine in p27Kip1 prevents pituitary tumorigenesis by two-hit loss of Rb1 and enhances humoral immunity in old age |
| Q35177573 | T cell immunostimulation by methyl inosine 5'-monophosphate: application to infectious diseases |
| Q43682312 | The use of Flt3 ligand as an adjuvant for hepatitis B vaccination of healthy adults |
| Q51903763 | Tracing thymic output in older individuals. |
| Q36960249 | Vaccine responses in patients with rheumatoid arthritis |
| Q37228972 | Zinc supplementation increases zinc status and thymopoiesis in aged mice |
| Q77165920 | [Acute hepatitis B in a previously vaccinated patient infected by the human immunodeficiency virus] |
Search more.